Skip to main navigation Skip to search Skip to main content

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

  • Mareike Berlak
  • , Elizabeth Tucker
  • , Mathurin Dorel
  • , Annika Winkler
  • , Aleixandria McGearey
  • , Elias Rodriguez-Fos
  • , Barbara Martins da Costa
  • , Karen Barker
  • , Elicia Fyle
  • , Elizabeth Calton
  • , Selma Eising
  • , Kim Ober
  • , Deborah Hughes
  • , Eleni Koutroumanidou
  • , Paul Carter
  • , Reda Stankunaite
  • , Paula Proszek
  • , Neha Jain
  • , Carolina Rosswog
  • , Heathcliff Dorado-Garcia
    • Jan Jasper Molenaar, Mike Hubank, Giuseppe Barone, John Anderson, Peter Lang, Hedwig Elisabeth Deubzer, Annette Künkele, Matthias Fischer, Angelika Eggert, Charlotte Kloft, Anton George Henssen, Michael Boettcher, Falk Hertwig, Nils Blüthgen, Louis Chesler, Johannes Hubertus Schulte

Research output: Contribution to journal › Article › peer-review

45 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Keyphrases